Hawryluk P. Kent

Hawryluk P. Kent is listed in filings as President & CEO at MBX Biosciences, Inc. Common Stock. This profile follows SEC Form 4 activity through May 8, 2026, including sale activity and purchase activity. Recent filings connect the profile to MBX Biosciences, Inc. Common Stock (MBX). The current snapshot covers public activity from Oct 21, 2025 to May 8, 2026. Reported amounts are shown as $17.9K to $460.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.